Conference on pancreatic diseases and new treatment targets
Official title: 2025 Pancreatic Diseases Gordon Research Conference
Funded at Gordon Research Conferences · NIH-11165695 · Data updated 2026-11-12
This conference is a friendly gathering for experts to share new ideas and discoveries about pancreatic diseases like diabetes and cancer, helping to improve understanding and treatment for everyone affected by these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gordon Research Conferences NIH-funded |
| Lab location | 1 site (East Greenwich, UNITED STATES) |
| Project start | June 11, 2025 |
| Project end | March 14, 2026 |
| Funding year | 2025 |
| Award (this year) | $25,000 |
| NIH project number | 1R13DK143687-01 |
| Project ID | NIH-11165695 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with pancreatic diseases such as diabetes, pancreatitis, or pancreatic cancer may benefit from the advancements discussed at this conference.
✕Less likely to help
Patients with unrelated health conditions or those not affected by pancreatic diseases may not receive direct benefits from this research.
What this research studies
This conference aims to bring together leading experts in pancreatic diseases to discuss the latest findings in the molecular mechanisms of pancreatic development, injury, and diseases such as diabetes and cancer. Attendees will share unpublished research and explore innovative technologies that model pancreatic processes, fostering collaboration between different scientific communities. The event will also include a trainee-led seminar to encourage the next generation of researchers in this field. By promoting interdisciplinary dialogue, the conference seeks to address knowledge gaps and enhance understanding of the relationships between various pancreatic conditions.
Why it matters
Potential benefit: If successful, this conference could lead to new insights and therapeutic targets for treating pancreatic diseases, ultimately improving patient outcomes.
How similar studies have gone: Previous Gordon Research Conferences have successfully advanced understanding and treatment approaches in various medical fields, indicating a strong potential for impactful outcomes in this area as well.
Where this research is happening
-
Gordon Research Conferences
East Greenwich, United States Active
Researchers
- Principal investigator: Evans-Molina, Carmella — Gordon Research Conferences
- Study coordinator: Evans-Molina, Carmella
Related research
Other NIH-funded projects on the same topics.
-
Understanding how inflammation affects pancreatic diseases
This study is looking at how inflammation affects pancreatic diseases, like pancreatitis and pancreatic cancer, to find new ways to prevent and treat these conditions, which could help patients in the future.
-
Intensive 4-week postoperative multimodal rehab after proximal pancreatic surgery
This study tests whether a 4-week multimodal rehabilitation program can help adults who have severe complications after proximal pancreatic surgery recover better.
-
New lipase NHS7108 safety and potential efficacy in adults with exocrine pancreatic insufficiency
A 2-period study tests whether the new lipase NHS7108 works safely for adults with EPI by comparing it to the standard pancrelipase (Zenpep) at several doses over 14 days each.
-
Dabrafenib and trametinib for rare cancers with BRAF V600 mutations
This arm tests whether dabrafenib and trametinib can help adults, children, and teens with cancers that have a BRAF V600 mutation.
-
Early diagnosis of pancreatic cancer using duodenal fluid biomarkers
This project will see if pancreatic fluid collected during routine endoscopy can help detect early pancreatic cancer in adults.
-
Paracetamol with ibuprofen versus paracetamol with metamizole for pain in children with acute pancreatitis
We will test whether IV paracetamol combined with ibuprofen or IV paracetamol combined with metamizole reduces pain more effectively in children aged 3–18 with acute pancreatitis.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.